Aptevo Therapeutics Inc. (APVO)
4.61
0.06 (1.32%)
At close: Jan 15, 2025, 3:59 PM
4.77
3.47%
After-hours Jan 15, 2025, 04:50 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| PE Ratio | -4.71 | 10.30 | -49.98 | -249.25 | -24.45 | -19.69 | 480.00 | -16.25 | -100.95 | -117.15 | -112.27 |
| PS Ratio | n/a | 141.13 | 111.05 | 1.07K | 30.50 | 45.83 | 228.34 | 50.15 | 178.21 | 131.23 | 35.22K |
| PB Ratio | 6.70 | 24.45 | 1.12K | 277.10 | 83.51 | 34.77 | 40.80 | 36.14 | 67.57 | 63.29 | n/a |
| P/FCF Ratio | -6.99 | -20.88 | -60.96 | -156.37 | -23.25 | -20.18 | -77.88 | -46.41 | -119.08 | -124.76 | -114.25 |
| P/OCF Ratio | -6.99 | -20.91 | -62.97 | -156.84 | -23.33 | -20.56 | -80.51 | -49.57 | -122.81 | -127.39 | -116.52 |
| OCF/S Ratio | n/a | -6.75 | -1.76 | -6.8 | -1.31 | -2.23 | -2.84 | -1.01 | -1.45 | -1.03 | -302.31 |
| Debt / Equity Ratio | 0.44 | 0.53 | 13.75 | 1.65 | 1.96 | 0.63 | 0.23 | 0.36 | n/a | n/a | n/a |
| Quick Ratio | 2.64 | 2.97 | 1.42 | 2.92 | 0.62 | 2.66 | 5.08 | 3.31 | 0.74 | 1.21 | n/a |
| Current Ratio | 2.64 | 3.15 | 1.51 | 3.25 | 0.78 | 2.76 | 5.14 | 3.65 | 1.76 | 2.09 | n/a |
| Asset Turnover | n/a | 0.09 | 0.22 | 0.08 | 0.61 | 0.34 | 0.13 | 0.40 | 0.30 | 0.38 | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -1.42 | 2.37 | -22.46 | -1.11 | -3.42 | -1.77 | 0.09 | -2.22 | -0.67 | -0.54 | n/a |
| Return on Assets (ROA) | -0.7 | 1.25 | -0.48 | -0.34 | -0.76 | -0.8 | 0.06 | -1.22 | -0.53 | -0.43 | n/a |
| Return on Capital (ROIC) | -1.64 | -1.12 | -0.98 | -0.7 | -2.7 | -1.04 | -0.55 | -1.76 | -0.66 | -0.51 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | 71.07% | -54.52% | -314.3% | 38.54% | 51.39% | 65.82% | 33.63% | 49.61% | 64.38% | -22.30K% |
| Net Profit Margin | n/a | 1.37K% | -222.2% | -428.13% | -124.75% | -232.75% | 47.57% | -308.54% | -176.53% | -112.02% | -31.37K% |
| Pretax Profit Margin | n/a | 225.24% | -239.25% | -717.64% | -132.82% | -232.75% | -381.31% | -350.65% | -182.55% | -113.33% | -31.37K% |
| Operating Profit Margin | n/a | -919.75% | -174.1% | -638.06% | -126.33% | -223.98% | -368.05% | -348.42% | -181.84% | -112.84% | -31.39K% |
| FCF Margin | n/a | -676.01% | -182.17% | -682.43% | -131.19% | -227.16% | -293.18% | -108.07% | -149.66% | -105.18% | -30.83K% |
| EBITDA Margin | n/a | -890.82% | -164.79% | -605.43% | -121.91% | -213.62% | -346.72% | -176.75% | -173.19% | -108.42% | -30.99K% |